Slc46a3 Rat (+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC46A3 mRNA] CTD PMID:31150632 Slc46a3 Rat (-)-epigallocatechin 3-gallate multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC46A3 mRNA CTD PMID:22079256 Slc46a3 Rat 1,1-dichloroethene decreases expression ISO Slc46a3 (Mus musculus) 6480464 vinylidene chloride results in decreased expression of SLC46A3 mRNA CTD PMID:26682919 Slc46a3 Rat 1,2-dimethylhydrazine decreases expression ISO Slc46a3 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of SLC46A3 mRNA CTD PMID:22206623 Slc46a3 Rat 17beta-estradiol multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in increased expression of SLC46A3 mRNA CTD PMID:30165855 Slc46a3 Rat 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of SLC46A3 mRNA CTD PMID:32145629 Slc46a3 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Slc46a3 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin binds to AHR protein] which results in increased expression of SLC46A3 mRNA and [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in increased expression of SLC46A3 mRNA CTD PMID:16214954 and PMID:25975270 Slc46a3 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Slc46a3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC46A3 mRNA CTD PMID:19770486 more ... Slc46a3 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc46a3 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC46A3 mRNA CTD PMID:20702594 and PMID:26377647 Slc46a3 Rat 2,3,7,8-Tetrachlorodibenzofuran affects expression ISO Slc46a3 (Mus musculus) 6480464 2 more ... CTD PMID:20702594 Slc46a3 Rat 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SLC46A3 mRNA CTD PMID:28628672 Slc46a3 Rat 4,4'-sulfonyldiphenol decreases expression ISO Slc46a3 (Mus musculus) 6480464 bisphenol S results in decreased expression of SLC46A3 mRNA CTD PMID:33297965 Slc46a3 Rat 7,12-dimethyltetraphene increases expression ISO Slc46a3 (Mus musculus) 6480464 9 more ... CTD PMID:32553695 Slc46a3 Rat acetamide decreases expression EXP 6480464 acetamide results in decreased expression of SLC46A3 mRNA CTD PMID:31881176 Slc46a3 Rat acrylamide affects expression EXP 6480464 Acrylamide affects the expression of SLC46A3 mRNA CTD PMID:28959563 Slc46a3 Rat aflatoxin B1 decreases expression ISO SLC46A3 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of SLC46A3 mRNA CTD PMID:27153756 Slc46a3 Rat aristolochic acid A increases expression ISO SLC46A3 (Homo sapiens) 6480464 aristolochic acid I results in increased expression of SLC46A3 mRNA CTD PMID:33212167 Slc46a3 Rat atrazine affects methylation EXP 6480464 Atrazine affects the methylation of SLC46A3 gene CTD PMID:28931070 Slc46a3 Rat benzo[a]pyrene increases expression ISO Slc46a3 (Mus musculus) 6480464 Benzo(a)pyrene metabolite results in increased expression of SLC46A3 mRNA and Benzo(a)pyrene results in increased expression of SLC46A3 mRNA CTD PMID:19770486 more ... Slc46a3 Rat benzo[a]pyrene decreases expression ISO SLC46A3 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of SLC46A3 mRNA CTD PMID:32234424 Slc46a3 Rat benzo[a]pyrene affects methylation ISO SLC46A3 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLC46A3 promoter CTD PMID:27901495 Slc46a3 Rat benzo[a]pyrene multiple interactions ISO Slc46a3 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC46A3 mRNA and [Benzo(a)pyrene results in increased activity of AHR protein] which results in increased expression of SLC46A3 mRNA CTD PMID:27858113 and PMID:32553695 Slc46a3 Rat benzo[b]fluoranthene multiple interactions ISO Slc46a3 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC46A3 mRNA CTD PMID:27858113 Slc46a3 Rat Benzo[k]fluoranthene increases expression ISO Slc46a3 (Mus musculus) 6480464 benzo(k)fluoranthene results in increased expression of SLC46A3 mRNA CTD PMID:26377693 Slc46a3 Rat bis(2-chloroethyl) sulfide increases expression ISO SLC46A3 (Homo sapiens) 6480464 Mustard Gas results in increased expression of SLC46A3 mRNA CTD PMID:25102026 Slc46a3 Rat bis(2-ethylhexyl) phthalate increases expression ISO SLC46A3 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of SLC46A3 mRNA CTD PMID:31163220 Slc46a3 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC46A3 mRNA CTD PMID:30816183 and PMID:32528016 Slc46a3 Rat bisphenol A decreases expression ISO Slc46a3 (Mus musculus) 6480464 bisphenol A results in decreased expression of SLC46A3 mRNA CTD PMID:32156529 Slc46a3 Rat bisphenol A decreases methylation ISO SLC46A3 (Homo sapiens) 6480464 bisphenol A results in decreased methylation of SLC46A3 gene CTD PMID:31601247 Slc46a3 Rat bisphenol A increases expression ISO Slc46a3 (Mus musculus) 6480464 bisphenol A results in increased expression of SLC46A3 mRNA CTD PMID:34585602 Slc46a3 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of SLC46A3 mRNA CTD PMID:32145629 Slc46a3 Rat bisphenol F multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SLC46A3 mRNA CTD PMID:28628672 Slc46a3 Rat cadmium atom multiple interactions ISO Slc46a3 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC46A3 mRNA CTD PMID:37325564 Slc46a3 Rat cadmium dichloride multiple interactions ISO Slc46a3 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC46A3 mRNA CTD PMID:37325564 Slc46a3 Rat carbon nanotube decreases expression ISO Slc46a3 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 Slc46a3 Rat cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of SLC46A3 mRNA CTD PMID:18500788 Slc46a3 Rat chlorpyrifos increases expression ISO Slc46a3 (Mus musculus) 6480464 Chlorpyrifos results in increased expression of SLC46A3 mRNA CTD PMID:32715474 Slc46a3 Rat chromium(6+) decreases expression ISO SLC46A3 (Homo sapiens) 6480464 chromium hexavalent ion results in decreased expression of SLC46A3 mRNA CTD PMID:30690063 Slc46a3 Rat chrysene multiple interactions ISO Slc46a3 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC46A3 mRNA CTD PMID:27858113 Slc46a3 Rat cisplatin multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [Cisplatin co-treated with jinfukang] results in increased expression of SLC46A3 mRNA CTD PMID:27392435 Slc46a3 Rat clofibrate decreases expression ISO Slc46a3 (Mus musculus) 6480464 Clofibrate results in decreased expression of SLC46A3 mRNA CTD PMID:23811191 Slc46a3 Rat cyclosporin A decreases expression ISO SLC46A3 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of SLC46A3 mRNA CTD PMID:20106945 Slc46a3 Rat dexamethasone multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SLC46A3 mRNA CTD PMID:28628672 Slc46a3 Rat dibenzofurans increases expression ISO Slc46a3 (Mus musculus) 6480464 Dibenzofurans results in increased expression of SLC46A3 mRNA CTD PMID:34254344 Slc46a3 Rat Dibutyl phosphate affects expression ISO SLC46A3 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of SLC46A3 mRNA CTD PMID:37042841 Slc46a3 Rat dichloroacetic acid decreases expression ISO Slc46a3 (Mus musculus) 6480464 Dichloroacetic Acid results in decreased expression of SLC46A3 mRNA CTD PMID:28962523 Slc46a3 Rat diclofenac decreases expression ISO Slc46a3 (Mus musculus) 6480464 Diclofenac results in decreased expression of SLC46A3 mRNA CTD PMID:35537566 Slc46a3 Rat dioxygen increases expression ISO SLC46A3 (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of SLC46A3 mRNA CTD PMID:26516004 Slc46a3 Rat dorsomorphin multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Slc46a3 Rat doxorubicin decreases expression ISO SLC46A3 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of SLC46A3 mRNA CTD PMID:29803840 Slc46a3 Rat entinostat increases expression ISO SLC46A3 (Homo sapiens) 6480464 entinostat results in increased expression of SLC46A3 mRNA CTD PMID:27188386 Slc46a3 Rat epoxiconazole affects expression ISO Slc46a3 (Mus musculus) 6480464 epoxiconazole affects the expression of SLC46A3 mRNA CTD PMID:35436446 Slc46a3 Rat ethylparaben increases expression ISO SLC46A3 (Homo sapiens) 6480464 ethyl-p-hydroxybenzoate results in increased expression of SLC46A3 mRNA CTD PMID:37690743 Slc46a3 Rat ferric oxide decreases expression ISO Slc46a3 (Mus musculus) 6480464 ferric oxide analog results in decreased expression of SLC46A3 mRNA CTD PMID:25086211 Slc46a3 Rat gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of SLC46A3 mRNA CTD PMID:33387578 Slc46a3 Rat glafenine decreases expression EXP 6480464 Glafenine results in decreased expression of SLC46A3 mRNA CTD PMID:24136188 Slc46a3 Rat indometacin multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SLC46A3 mRNA CTD PMID:28628672 Slc46a3 Rat isotretinoin decreases expression ISO SLC46A3 (Homo sapiens) 6480464 Isotretinoin results in decreased expression of SLC46A3 mRNA CTD PMID:20436886 Slc46a3 Rat lipopolysaccharide multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SLC46A3 mRNA CTD PMID:35811015 Slc46a3 Rat lipopolysaccharide decreases expression ISO SLC46A3 (Homo sapiens) 6480464 Lipopolysaccharides results in decreased expression of SLC46A3 mRNA CTD PMID:35811015 Slc46a3 Rat metformin decreases expression EXP 6480464 Metformin results in decreased expression of SLC46A3 mRNA CTD PMID:31324951 Slc46a3 Rat Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of SLC46A3 mRNA CTD PMID:21515302 Slc46a3 Rat nickel sulfate increases expression ISO SLC46A3 (Homo sapiens) 6480464 nickel sulfate results in increased expression of SLC46A3 mRNA CTD PMID:22714537 Slc46a3 Rat oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of SLC46A3 mRNA CTD PMID:25729387 Slc46a3 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC46A3 mRNA CTD PMID:25729387 Slc46a3 Rat paracetamol affects expression ISO Slc46a3 (Mus musculus) 6480464 Acetaminophen affects the expression of SLC46A3 mRNA CTD PMID:17562736 Slc46a3 Rat paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of SLC46A3 mRNA CTD PMID:33387578 Slc46a3 Rat paracetamol decreases expression ISO SLC46A3 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of SLC46A3 mRNA CTD PMID:29067470 Slc46a3 Rat perfluorohexanesulfonic acid increases expression ISO Slc46a3 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of SLC46A3 mRNA CTD PMID:37995155 Slc46a3 Rat perfluorononanoic acid decreases expression ISO SLC46A3 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of SLC46A3 mRNA CTD PMID:32588087 Slc46a3 Rat phenylmercury acetate increases expression ISO SLC46A3 (Homo sapiens) 6480464 Phenylmercuric Acetate results in increased expression of SLC46A3 mRNA CTD PMID:26272509 Slc46a3 Rat phenylmercury acetate multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC46A3 mRNA CTD PMID:27188386 Slc46a3 Rat pirinixic acid multiple interactions ISO Slc46a3 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of SLC46A3 mRNA CTD PMID:19710929 Slc46a3 Rat pirinixic acid decreases expression ISO Slc46a3 (Mus musculus) 6480464 pirinixic acid results in decreased expression of SLC46A3 mRNA CTD PMID:23811191 Slc46a3 Rat potassium chromate multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SLC46A3 mRNA CTD PMID:22079256 Slc46a3 Rat potassium chromate decreases expression ISO SLC46A3 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of SLC46A3 mRNA CTD PMID:22079256 and PMID:22714537 Slc46a3 Rat pregnenolone 16alpha-carbonitrile decreases expression ISO Slc46a3 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in decreased expression of SLC46A3 mRNA CTD PMID:28903501 Slc46a3 Rat progesterone increases expression ISO SLC46A3 (Homo sapiens) 6480464 Progesterone results in increased expression of SLC46A3 mRNA CTD PMID:20864642 Slc46a3 Rat resveratrol multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in increased expression of SLC46A3 mRNA CTD PMID:23557933 Slc46a3 Rat rifampicin increases expression ISO SLC46A3 (Homo sapiens) 6480464 Rifampin results in increased expression of SLC46A3 mRNA CTD PMID:27199754 Slc46a3 Rat rotenone increases expression EXP 6480464 Rotenone results in increased expression of SLC46A3 mRNA CTD PMID:28374803 Slc46a3 Rat S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [S-(1 and 2-dichlorovinyl)cysteine affects the susceptibility to Lipopolysaccharides] which results in increased expression of SLC46A3 mRNA CTD PMID:35811015 Slc46a3 Rat SB 431542 multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 Slc46a3 Rat silicon dioxide decreases expression ISO SLC46A3 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of SLC46A3 mRNA CTD PMID:25895662 Slc46a3 Rat silicon dioxide increases expression ISO SLC46A3 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of SLC46A3 mRNA and Silicon Dioxide results in increased expression of SLC46A3 mRNA CTD PMID:23806026 and PMID:25351596 Slc46a3 Rat sodium arsenite increases expression ISO SLC46A3 (Homo sapiens) 6480464 sodium arsenite results in increased expression of SLC46A3 mRNA CTD PMID:38568856 Slc46a3 Rat sodium arsenite decreases expression ISO Slc46a3 (Mus musculus) 6480464 sodium arsenite results in decreased expression of SLC46A3 mRNA CTD PMID:37668303 Slc46a3 Rat Soman decreases expression EXP 6480464 Soman results in decreased expression of SLC46A3 mRNA CTD PMID:19281266 Slc46a3 Rat sunitinib decreases expression ISO SLC46A3 (Homo sapiens) 6480464 Sunitinib results in decreased expression of SLC46A3 mRNA CTD PMID:31533062 Slc46a3 Rat Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of SLC46A3 mRNA CTD PMID:21515302 Slc46a3 Rat tetrachloroethene decreases expression ISO Slc46a3 (Mus musculus) 6480464 Tetrachloroethylene results in decreased expression of SLC46A3 mRNA CTD PMID:28973375 Slc46a3 Rat tetrachloromethane decreases expression ISO Slc46a3 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of SLC46A3 mRNA CTD PMID:27339419 and PMID:31919559 Slc46a3 Rat tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of SLC46A3 mRNA] CTD PMID:31150632 Slc46a3 Rat tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of SLC46A3 mRNA CTD PMID:31150632 Slc46a3 Rat tetraphene multiple interactions ISO Slc46a3 (Mus musculus) 6480464 [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of SLC46A3 mRNA CTD PMID:27858113 Slc46a3 Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SLC46A3 mRNA CTD PMID:23411599 and PMID:34492290 Slc46a3 Rat topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of SLC46A3 mRNA CTD PMID:25729387 Slc46a3 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of SLC46A3 mRNA CTD PMID:25729387 Slc46a3 Rat tremolite asbestos decreases expression ISO Slc46a3 (Mus musculus) 6480464 tremolite results in decreased expression of SLC46A3 mRNA CTD PMID:29279043 Slc46a3 Rat trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of SLC46A3 mRNA CTD PMID:33387578 Slc46a3 Rat trichostatin A increases expression ISO SLC46A3 (Homo sapiens) 6480464 trichostatin A results in increased expression of SLC46A3 mRNA CTD PMID:24935251 Slc46a3 Rat triphenyl phosphate affects expression ISO SLC46A3 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of SLC46A3 mRNA CTD PMID:37042841 Slc46a3 Rat trovafloxacin decreases expression ISO Slc46a3 (Mus musculus) 6480464 trovafloxacin results in decreased expression of SLC46A3 mRNA CTD PMID:35537566 Slc46a3 Rat valproic acid increases expression ISO Slc46a3 (Mus musculus) 6480464 Valproic Acid results in increased expression of SLC46A3 mRNA CTD PMID:21427059 Slc46a3 Rat valproic acid increases expression ISO SLC46A3 (Homo sapiens) 6480464 Valproic Acid results in increased expression of SLC46A3 mRNA CTD PMID:19101580 more ... Slc46a3 Rat valproic acid multiple interactions ISO SLC46A3 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SLC46A3 mRNA CTD PMID:27188386 Slc46a3 Rat valproic acid affects expression ISO SLC46A3 (Homo sapiens) 6480464 Valproic Acid affects the expression of SLC46A3 mRNA CTD PMID:25979313 Slc46a3 Rat vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of SLC46A3 mRNA CTD PMID:23034163 Slc46a3 Rat zoledronic acid increases expression ISO SLC46A3 (Homo sapiens) 6480464 zoledronic acid results in increased expression of SLC46A3 mRNA CTD PMID:24714768